O

Otsuka Pharmaceutical

Global pharma maker of Abilify

Associate Director, Clinical Outcome Assessments

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • A bachelor's degree in outcomes research, health services research, epidemiology, psychology, public health, or a related field is required.
  • At least 7 years of relevant COA/PRO or patient-centered outcomes research experience, including at least 5 years specific to patient-centered/COA work.
  • Demonstrated experience independently designing and executing COA evidence-generation projects.
  • Working knowledge of FDA/EMA patient-focused drug development guidances and their application to clinical development.
  • Comprehensive understanding of the pharmaceutical industry, global regulatory requirements, and product development processes at all lifecycle stages.
  • Strong knowledge of the legal and regulatory environment influencing clinical development plans, labeling, and promotional claims.
  • Experience partnering and collaborating with external vendors and academic/clinical investigators.
  • Written and verbal communication skills sufficient to present technical COA concepts to cross-functional and senior audiences.

Responsibilities

  • Develop and execute COA strategy for one or more assigned clinical programs, applying qualitative and quantitative methods to support endpoint selection, evidence generation, and regulatory dossier input.
  • Identify fit-for-purpose COAs (PRO, ClinRO, ObsRO, PerfO) for assigned programs in the context of label claims, regulatory submissions, and value evidence needs.
  • Apply qualitative methods, including concept elicitation, concept confirmation, and cognitive debriefing, and quantitative/psychometric methods to determine measurement properties, responder definitions, and meaningful change.
  • Investigate whether COA endpoints are available, fit-for-purpose, and have regulatory precedent for assigned programs in support of the product target label claim and value evidence needs.
  • Design and lead generation of qualitative and quantitative COA evidence for assigned programs in accordance with international scientific standards and health authority guidance.
  • Contribute COA sections to regulatory dossiers, briefing packages, and health authority responses for assigned programs.
  • Lead development of Patient Experience and COA evidence dossiers for external stakeholders, including regulatory and health authorities.
  • Coordinate COA licensing, translation, linguistic validation, and rater training for assigned programs in collaboration with Global Clinical Development and Clinical Management.
  • Serve as the COA point of contact on assigned clinical study teams and represent COA in cross-functional program governance.
  • Represent Otsuka at relevant external conferences and working groups, such as ISPOR and ISOQOL, as assigned.
  • Build and maintain relationships with academic institutions, patient advocacy groups, clinical investigators, data vendors, and other vendors relevant to assigned programs.

Desired Qualifications

  • A master's or doctoral degree in a relevant field.
  • Experience supporting a regulatory submission (NDA/BLA/MAA) with COA content.
  • Prior conference presentation or publication in COA/PRO methodology.
  • Experience across multiple therapeutic areas.

About the Company

Otsuka Pharmaceutical

Global pharma maker of Abilify

Otsuka Pharmaceutical develops and markets medicines and health products worldwide, including prescription drugs and nutraceutical beverages. Its product lineup ranges from pharmaceutical treatments such as Abilify (an antipsychotic) to consumer health drinks like Pocari Sweat, which helps replenish electrolytes. Abilify works as a psychiatric medication used to treat conditions such as schizophrenia and bipolar disorder, while Pocari Sweat is an ion-replacement beverage designed to restore minerals and fluids after activity or heat. The company differentiates itself through a long history dating back to its founding in 1921, a broad, globally scaled portfolio spanning drugs and health beverages, and a focus on health improvements across populations. Its stated goal is to create new products for better health worldwide.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Tokyo, Japan
Founded
1921

Recently Posted Jobs

Explore more opportunities at Otsuka Pharmaceutical

See more jobs